Skip to content

Prelude Therapeutics sets terms of $150M IPO

September 21, 2020

Prelude Therapeutics (PRLD) will price its IPO of 8.325M common shares between $17 – 19 per share yielding ~$150M at the midpoint.

https://seekingalpha.com/news/3615705-prelude-therapeutics-sets-terms-of-150m-ipo

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: